neurological disorders
| 4 min read
Phase 3 trial results for neurological drugs, an AI platform for central nervous system drug discovery, a novel long-acting flu antiviral, and more led the news this week.
| 3 min read
PRISM brings together three organizations to standardize and distribute patient-derived iPSC motor neuron models that better represent the biological diversity of ALS.
| 4 min read
Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.
| 3 min read
Researchers are using caraway seeds to create synthetic cannabidiol compounds for treating seizures.
| 6 min read
New software and hardware tools that collect data while a person types can detect fine motor impairment — a possible sign of neurodegeneration.
| 8 min read
Lundbeck Therapeutics is testing a monoclonal antibody that targets a novel neuropeptide in a Phase 2b clinical trial.
| 5 min read
A drug class that blocks a neuronal receptor’s activity could help stroke patients quickly regain their senses of touch and control over movements.
| 7 min read
Membraneless droplet like organelles known as condensates are changing the way some scientists approach drug discovery.
Page 1 of 1 - 8 Total Items
